Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Lancet HIV. 2019 Jul 11;6(8):e531–e539. doi: 10.1016/S2352-3018(19)30148-1

Table 3.

Comparison of multi-state Markov model projections and validation targets.

Mean deviation from
regional stratified model projections
Regional validation targets Northeast South West
CD4 during ART
  ≥500 −2.1% 0.0% −2.2%
  200–499 0.6% 1.6% −7.4%
  <200 1.0% 6.3% −7.1%
Off-ART 15.9% 3.5% 22.7%
Mortality −4.4% −11.8% −18.4%

ART: Antiretroviral treatment; CD4: CD4 T-lymphocyte cell count per µL.